In the published article, there was an error in the Conflict of Interest statement. “SM was employed by the company OncoTreatments Pvt Ltd. AS declares that he is the Chief Scientific Officer of Oncotherm Kft. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.” The correct Conflict of Interest appears below.
In the published article, there was an error in the Funding statement. Missing grant supporting this manuscript. The correct Funding statement appears below.
Funding
This work was not supported by a company, but it was supported by the Hungarian Ministry of Finance grant: PM/15237-13/2020.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Statements
Conflict of interest
SM was employed by the company OncoTreatments Pvt Ltd. AS declares that he is the Chief Scientific Officer of Oncotherm Kft./GmbH. OS declares that he is employed by Oncotherm Kft./GmbH.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
SARS-CoV-21, rehabilitation, electric field, immune-effect, heat-shock protein, modulated electro-hyperthermia
Citation
Masaud SM, Szasz O, Szasz AM, Ejaz H, Anwar RA and Szasz A (2022) Corrigendum: A potential bioelectromagnetic method to slow down the progression and prevent the development of ultimate pulmonary fibrosis by COVID-19. Front. Immunol. 13:1094086. doi: 10.3389/fimmu.2022.1094086
Received
09 November 2022
Accepted
10 November 2022
Published
22 November 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
13 - 2022
Updates
Copyright
© 2022 Masaud, Szasz, Szasz, Ejaz, Anwar and Szasz.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Andras Szasz, Szasz.Andras@gek.szie.hu
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.